Morgan Stanley on Eli Lilly (LLY): 'we expect LLY shares to trade flat to slightly up'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY)
July 2, 2024 3:04 PM EDTBMO Capital analyst Evan David Seigerman reiterated an Outperform rating and $1,001.00 price target on Eli Lilly (NYSE: LLY).
The analyst comments "Approval of donanemab (branded Kisunla) is likely to expand revenue for both Lilly and Biogen/Eisai as two players are needed to grow infrastructure.... More
Eli Lilly Alzheimer's drug approved by US FDA
July 2, 2024 1:55 PM EDTBy Julie Steenhuysen and Mariam Sunny
(Reuters) -The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early Alzheimer's, making it the second therapy for slowing progression of the brain-wasting disease that will be available to U.S. patients.
The approval for donanemab, to be sold under the brand name Kisunla, followed the recommendations of the agency's outside experts, who unanimously backed its use in patients with early Alzheimer's disease, saying the benefits of the drug outweighed its risks.
This is real progress," said Joanne Pike of the Alzheimers Association. Having multiple... More
Biogen (BIIB) trades lower after after Lilly's Alzheimer's drug is approved
July 2, 2024 1:55 PM EDTShares of Biogen (NASDAQ: BIIB) are trading lower in midday on Tuesday, down nearly 3%, following FDA approval of Eli Lilly's (NYSE: LLY) competing drug to treat Alzheimer's disease.
Eli Lilly & Co. (LLY) Announces FDA Approval of Kisunla to Treat Early Symptomatic Alzheimer's Disease
July 2, 2024 1:36 PM EDTThe U.S. Food and Drug Administration (FDA) approved Kisunla (donanemab-azbt, 350 mg/20 mL once-monthly injection for IV infusion), Eli Lilly and Company's (NYSE: LLY) Alzheimer's treatment for adults with early symptomatic Alzheimer's disease (AD), which includes people with mild cognitive impairment (MCI) as well as people with the mild dementia stage of AD, with confirmed amyloid pathology.1, 2 Once-monthly Kisunla is the first and only amyloid plaque-targeting therapy with evidence to support stopping therapy when amyloid plaques are removed,... More
Midday movers: Tesla, Rivian rise; Novo Nordisk, Pure Storage fall
July 2, 2024 11:50 AM EDTInvesting.com Main U.S. indexes rose Tuesday after Fed Chairman Jerome Powell pointed out progress on inflation during a panel discussion with officials from the European Central Bank. Overall trading volumes were lighter than normal ahead of the holiday on Thursday.
Here are some of the biggest U.S. stock movers today:
Tesla (NASDAQ:... More
Eli Lilly & Co. (LLY) call put ratio 1 call to 1.2 puts with focus on August 870 and 890 calls
July 2, 2024 10:47 AM EDTEli Lilly & Co. (NYSE: LLY) 30-day option implied volatility is at 25; compared to its 52-week range of 19 to 39. Call put ratio 1 call to 1.2 puts with focus on August 870 and 890 calls.
... MoreNovo Nordisk, Eli Lilly stock slides after Biden op-ed calls for lower Ozempic, Wegovy Prices
July 2, 2024 9:12 AM EDTShares of Eli Lilly & Co. (NYSE: LLY) and Novo Nordisk (NYSE: NVO) fell by more than 2% and 3%, respectively, premarket Tuesday after U.S. President Joe Biden said Novo Nordisk must cut Ozempic and Wegovy... More
Biden Says Novo Nordisk (NVO) Must Cut Ozempic, Wegovy Prices
July 2, 2024 8:00 AM EDT(Updated - July 2, 2024 8:05 AM EDT)
(Updated - July 2, 2024 8:01 AM EDT)
Biden Says Novo Nordisk (NVO) Must Cut Ozempic, Wegovy Prices
Biden Comments In USA Today Op-ed With Senator Bernie... MoreRadionetics Oncology Enters Into Strategic Agreement With Lilly (LLY)
July 1, 2024 10:05 AM EDTRadionetics Oncology, a biotechnology company discovering and developing novel small molecule G protein coupled receptor (GPCR) targeted radiopharmaceuticals to treat a broad range of solid tumors, announced today the formation of a strategic relationship with Eli Lilly and Company to take forward Radionetics proprietary GPCR targeting small molecule radiopharmaceuticals.
Under the terms of the agreement, Radionetics received a $140 million upfront cash payment. As... More
Eli Lilly & Co. (LLY) option implied volatility flat as share price near record high
June 28, 2024 10:26 AM EDTEli Lilly & Co. (NYSE: LLY) 30-day option implied volatility is at 23; compared to its 52-week range of 19 to 39 as share price near record high.
... More